Schedule 13G ownership disclosure

Ultragenyx Pharmaceutical Inc

Security class unavailable · CUSIP: 90400D108

Event date: 2021-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,361,792
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-21-000160
Form type
SC 13G/A
Filer
Capital Research Global Investors
CIK
CIK 1422848
Filed
Oct 08, 2021
Reporting period
Sep 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub